Skip to main content

Table 3 IC50 for bladder cancer cell line in MTT assay

From: Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation

Cell line

IC50(μM) for Osthole

IC50(μM) for Cisplatin

5637

146.4 ± 8.2 (24 h)

13.2 ± 0.7 (24 h)

68.1 ± 4.4 (48 h)

8.14 ± 0.5 (48 h)

253 J

160.8 ± 9.7 (24 h)

17.0 ± 0.9 (24 h)

100.3 ± 3.3 (48 h)

9.7 ± 0.6 (48 h)

SV-HUC-1

271.1 ± 13.1 (24 h)

28.2 ± 2.0 (24 h)

211.2 ± 14.4 (48 h)

21.6 ± 1.3 (48 h)